SELLAS Life Sciences Group Inc sell Wolf_of_WS
Start price
16.08.26
/
50%
€11.25
Target price
16.08.27
-
Performance (%)
0.00%
Price
17.08.26
€11.25
Summary
This prediction is currently active. The SELL prediction by Wolf_of_WS is currently unchanged from the start price. This prediction currently runs until 16.08.27. The prediction end date can be changed by Wolf_of_WS at any time. Wolf_of_WS has 50% into this predictionSELLAS Life Sciences is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, is a cancer immunotherapy being developed for the treatment of acute myeloid leukemia (AML) and ovarian cancer. SELLAS Life Sciences is listed on the NASDAQ stock exchange under the symbol RXII.
AI-generated
Performance without dividends (%)
| Name | 1w |
|---|---|
| SELLAS Life Sciences Group Inc | 0.00% |
| iShares Core DAX® | -0.046% |
| iShares Nasdaq 100 | 0.922% |
| iShares Nikkei 225® | 3.014% |
| iShares S&P 500 | -0.359% |
Comments by Wolf_of_WS for this prediction
In the thread SELLAS Life Sciences Group Inc diskutieren
Sell SELLAS Life Sciences Group Inc
Stopped prediction by Wolf_of_WS for SELLAS Life Sciences Group Inc
SELLAS Life Sciences Group Inc
Start price
Target price
Perf. (%)
€1.52
05.03.23
05.03.23
-
05.03.24
05.03.24
-19.55%
17.03.23
17.03.23
